Jiří Horacek
Professor of Psychiatry; Head of the Department of Psychiatry and Medical Psychology at Charles University and the National Institute of Mental Health
Data updated
Research Footprint
Jiří Horacek appears in 6 tracked papers (2013–2023), most studied alongside Psilocybin, Ketamine and Placebo, across Depressive Disorders, Neuroimaging & Brain Measures and Major Depressive Disorder (MDD).
Most-cited paper: Psilocybin - Summary of knowledge and new perspectives (263 citations).
Frequent co-authors: Tomáš Páleníček, Martin Brunovský and František Tylš.
Background & Research
Jiří Horáček is a Czech psychiatrist, psychotherapist, and neuroscientist who earned his medical degree from Charles University and later became professor of psychiatry. He leads the Department of Psychiatry and Medical Psychology at the Third Faculty of Medicine, Charles University, and has also served in senior research leadership at the National Institute of Mental Health. His research focuses on the neurobiology and clinical effects of psychedelics, ketamine, depression, schizophrenia, and brain imaging.
Key Impact
He is a leading Czech psychiatrist and neuroscientist whose work on ketamine and psychedelics has helped shape translational psychiatric research on rapid-acting antidepressant mechanisms.
Collaboration Network
8 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Jiří Horacek is associated with.